Evidence map›Paper›PMID 29618024›Full record

ArticleJournal of molecular cell biology2018

A novel long non-coding RNA Myolinc regulates myogenesis through TDP-43 and Filip1.

Giuseppe Militello, Mohammed Rabiul Hosen, Yuliya Ponomareva, Pascal Gellert, Tyler Weirick, David John, Sajedah Mahmoud Hindi, Kamel Mamchaoui, Vincent Mouly, Claudia Döring and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of molecular cell biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 71 citations in OpenAlex.

  1. Review of the Pathology of Muscle in Amyotrophic Lateral Sclerosis.International journal of molecular sciences · 2026
    Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Implications of TDP-43 in non-neuronal systems.Cell communication and signaling : CCS · 2023
    Review
  8. Skeletal muscle in amyotrophic lateral sclerosis.Brain : a journal of neurology · 2023
    Review
  9. Article
  10. Review
  11. TDP-43 Epigenetic Facets and Their Neurodegenerative Implications.International journal of molecular sciences · 2023
    Review
  12. Article
  13. LncRNAInternational journal of molecular sciences · 2023
    Article
  14. Article
  15. Review
  16. Regulation of muscle stem cell fate.Cell regeneration (London, England) · 2022
    Review
  17. Long non-coding RNAEpigenetics · 2022
    Article
  18. Morphological and Molecular Responses ofInternational journal of molecular sciences · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 5 countries.

Giuseppe MilitelloInstitute of Cardiovascular Regeneration, Centre for Molecular Medicine, Goethe University Frankfurt, Frankfurt am Main 60590, Germany.
Mohammed Rabiul HosenInstitute of Cardiovascular Regeneration, Centre for Molecular Medicine, Goethe University Frankfurt, Frankfurt am Main 60590, Germany.
Yuliya PonomarevaInstitute of Cardiovascular Regeneration, Centre for Molecular Medicine, Goethe University Frankfurt, Frankfurt am Main 60590, Germany.
Pascal GellertBreast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, London SW3 6JB, UK.
Tyler WeirickInstitute of Cardiovascular Regeneration, Centre for Molecular Medicine, Goethe University Frankfurt, Frankfurt am Main 60590, Germany.
David JohnInstitute of Cardiovascular Regeneration, Centre for Molecular Medicine, Goethe University Frankfurt, Frankfurt am Main 60590, Germany.
Sajedah Mahmoud HindiDepartment of Anatomical Sciences and Neurobiology, University of Louisville School of Medicine, Louisville, KY 40202, USA.
Kamel MamchaouiSorbonne Universités, UPMC Univ Paris 06, INSERM UMRS974, CNRS FRE3617, Center for Research in Myology, Paris 75013, France.
Vincent MoulySorbonne Universités, UPMC Univ Paris 06, INSERM UMRS974, CNRS FRE3617, Center for Research in Myology, Paris 75013, France.
Claudia DöringDr. Senckenberg Institute of Pathology, Goethe University Frankfurt, Frankfurt am Main 60590, Germany.
Lidan ZhangLaboratory of Molecular and Cellular Physiology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.
Miki NakamuraLaboratory of Molecular and Cellular Physiology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.
Ashok KumarDepartment of Anatomical Sciences and Neurobiology, University of Louisville School of Medicine, Louisville, KY 40202, USA.
So-Ichiro FukadaLaboratory of Molecular and Cellular Physiology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.
Stefanie DimmelerInstitute of Cardiovascular Regeneration, Centre for Molecular Medicine, Goethe University Frankfurt, Frankfurt am Main 60590, Germany.
Shizuka UchidaInstitute of Cardiovascular Regeneration, Centre for Molecular Medicine, Goethe University Frankfurt, Frankfurt am Main 60590, Germany.
Goethe University Frankfurt · DEThe University of Osaka · JPCentre National de la Recherche Scientifique · FRUniversity of Louisville · USInstitute of Cancer Research · GB

Funding

MYD88 Signaling in Mammalian Myoblast FusionR01AR068313 · NIAMS · UNIVERSITY OF LOUISVILLE · PI KUMAR, ASHOK · 2015 to 2019
$1.7M
NIAMS NIH HHS R01 AR068313
6 · The paper itself

Abstract

Myogenesis is a complex process required for skeletal muscle formation during embryonic development and for regeneration and growth of myofibers in adults. Accumulating evidence suggests that long non-coding RNAs (lncRNAs) play key roles in regulating cell fate decision and function in various tissues. However, the role of lncRNAs in the regulation of myogenesis remains poorly understood. In this study, we identified a novel muscle-enriched lncRNA called 'Myolinc (AK142388)', which we functionally characterized in the C2C12 myoblast cell line. Myolinc is predominately localized in the nucleus, and its levels increase upon induction of the differentiation. Knockdown of Myolinc impairs the expression of myogenic regulatory factors and formation of multi-nucleated myotubes in cultured myoblasts. Myolinc also regulates the expression of Filip1 in a cis-manner. Similar to Myolinc, knockdown of Filip1 inhibits myogenic differentiation. Furthermore, Myolinc binds to TAR DNA-binding protein 43 (TDP-43), a DNA/RNA-binding protein that regulates the expression of muscle genes (e.g. Acta1 and MyoD). Knockdown of TDP-43 inhibits myogenic differentiation. We also show that Myolinc-TDP-43 interaction is essential for the binding of TDP-43 to the promoter regions of muscle marker genes. Finally, we show that silencing of Myolinc inhibits skeletal muscle regeneration in adult mice. Altogether, our study identifies a novel lncRNA that controls key regulatory networks of myogenesis.

Indexed as

Gene Expression RegulationMuscle DevelopmentAnimalsCarrier ProteinsCell DifferentiationCell LineCells, CulturedDNA-Binding ProteinsGene Knockdown TechniquesMiceMice, Inbred C57BLMuscle Fibers, SkeletalMyoblastsProtein Interaction MapsRNA, Long NoncodingCarrier ProteinsDNA-Binding ProteinsFILIP protein, mouseRNA, Long NoncodingTardbp protein, mouse

Identifiers

PMID29618024
PMCPMC7191624
OpenAlexW2796142984

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.